Viewing Study NCT02962895


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-06-01 @ 2:10 AM
Study NCT ID: NCT02962895
Status: COMPLETED
Last Update Posted: 2025-01-07
First Post: 2016-11-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CVAY736A2201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators